More Doping Confessions to Come

    Paris, France:  US Lance Armstrong rides during the 21st stage of the 92nd Tour de France cycling race between Corbeil-Essonnes and the Champs-Elysees in Paris, 24 July 2005. US Lance Armstrong secured his seventh Tour de France yellow jersey following the 21st and final stage of this year's race held over 144km between Corbeil-Essone and here Sunday.The 33-year-old Discovery Channel team rider finished the race with a 4min 40sec lead on Italian Ivan Basso with Germany's Jan Ullrich, the 1997 winner, finishing third on the podium at 6:21 behind Armstrong.  AFP PHOTO JAVIER SORIANO  (Photo credit should read JAVIER SORIANO/AFP/Getty Images)

    Armstrong during 2005 Tour de France. (Javier Soriano/AFP/Getty)

    Lance Armstrong is just the beginning—get ready for plenty more doping confessions to come, writes Jonathan Mahler in Friday’s New York Post. The news that a stage IV cancer survivor could go on to win the Tour de France shouldn’t have been a surprise to anyone—despite that journalists, teammates, and sports fans all seemed to be caught unaware by the revelation. Historically, drugs have been rampant in cycling. Many are even considered acceptable to use if a doctor prescribes them, begging the question: where does the moral line lie? Mahler points to the real reason steroids have become so popular—“because we value winning above all else, and we pay winners accordingly.”

    Read it at New York Post